Iovance Biotherapeutics, Inc.
Clinical trials sponsored by Iovance Biotherapeutics, Inc., explained in plain language.
-
Immune cells take on melanoma in latest trial
Disease control OngoingThis study tests a treatment called lifileucel, made from a patient's own immune cells (tumor-infiltrating lymphocytes), for advanced melanoma that has not responded to prior therapy. About 100 adults with unresectable or metastatic melanoma will receive this cell therapy. The ma…
Phase: PHASE2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
Immune cells from Patients' own tumors tested as new weapon against childhood cancers
Disease control OngoingThis early-stage study tests whether a treatment made from a patient's own tumor-fighting immune cells (TIL) is safe for children, teenagers, and young adults with solid tumors that have come back or stopped responding to standard treatments. About 40 participants will receive th…
Phase: PHASE1 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 12:04 UTC